Garry Blakely of the University of Edinburgh in the United Kingdom will engineer a common gut bacterium to express antigens from pathogens that cause diarrhea onto nanoscale outer membrane vesicles. These nanoparticles could be the basis for a new generation of biocompatible oral vaccines that will protect against diarrheal disease.